Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,193.6
-8.3 (-0.26%)

 

  • STI Straits Times Index
    3,193.6
    -8.3 (-0.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,586.2
    -1.8 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,132.0
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,609.9
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,105.1
    504.7 (1.76%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,625.7
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 257.0M
  • Value: 136.7M
  • Rise: 94
  • Fall: 71
  • Unch: 586

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.091+0.002
Hatten Land0.065+0.002
Beverly JCG0.001-
Mermaid Maritime0.107+0.011
Sinjia Land0.103+0.003
Net Pacific Fin0.036+0.002
QT Vascular0.006+0.001
Thomson Medical0.088-0.001
ThaiBev0.710-
Rex Intl0.355-0.005

World Indices

World Indices
Name Last Change
Nasdaq 15,226.7 +136.5
HSI 26,132.0
HSCEI 9,322.1
Jakarta 6,625.7
Nikkei 225 29,142.0 +541.6
SSE Comp 3,609.9
Shanghai A 3,783.3
Shanghai B 276.7
KOSPI 3,038.7 +18.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Merck Tbk. MERCK INDONESIA
Quotes 10 Minutes Delayed. No Trades for The Day
Last (IDR): 3,500.000 Change: - High: 3,500.000 Remarks: -
Change (%): - Low: 3,500.000
Open 3,500.000 Yesterday's Close 3500.000
Buy Price - Sell Price -
Buy Volume ('000) - Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 160.49612 Trailing EPS (IDR) e 270.81586 NAV (IDR) b 1,549.6093
PE a 21.807 Trailing PE f 12.924 Price / NAV b 2.2586
Dividend (IDR) d 122.000000 Cash In Hand (IDR) g 490.4504 Issued & Paid-up Shares c 448,000,000
Dividend Yield (%) d 3.486 Price / Cash In Hand g 7.136 Treasury Shares h -
Beta - 75 Daysi 0.428 R-Squared - 75 Days(%)i 4.83 Market Cap (M) 1,568,000.000
Beta - 500 Daysi 0.934 R-Squared - 500 Days (%)i 25.79 Enterprise Value (M) 1,370,937.640
Piotroski F Score 8 Exchange Code MERK Par Value ( IDR ) 50.00000
52 Weeks Volatility (%) 20.22 6-Month VWAP 3419.939 Free Float (%) 13.3
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 22 Dec 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Merck Tbk. IDX 1,568,000.000 21.807 12.924 2.2586 3.486
Industry Pharmaceuticals: Major IDX 5,650,714.063 72.880 50.767 2.1260 1.684
Local Peer Kimia Farma Tbk. IDX 13,551,760.002 768.291 508.240 1.9297 0.052
Local Peer Soho Global Health Tbk. IDX 6,504,496.250 37.793 28.558 2.9731 4.605
Local Peer Phapros Tbk. IDX 978,600.000 20.182 14.085 1.3464 1.982
Global Peer JOHNSON & JOHNSON NYSE 431,937.318 29.356 24.158 - 2.426
Global Peer PFIZER INC NYSE 241,928.674 25.159 18.289 3.4540 3.521
Global Peer ELI LILLY AND COMPANY NYSE 234,410.174 37.847 38.613 36.3743 1.208
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,933.251 25.140 22.588 3.7551 2.312
Global Peer MERCK & CO INC NYSE 206,711.674 29.250 37.105 6.2087 3.036
Global Peer ABBVIE INC NYSE 191,739.030 42.085 29.100 15.2548 4.456
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 191,442.103 59.901 50.767 12.2124 1.879
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 188,192.695 29.205 26.435 18.0001 1.267
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 128,460.179 - - 3.4900 3.214
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,144.845 8.986 18.216 1.6821 2.712
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), ALLAKOS INC (NASDAQ), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ATAI LIFE SCIENCES NV (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), EVEREST MEDICINES LTD (HKEx), QUANTERIX CORPORATION (NASDAQ), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), IGM BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), SSY GROUP LIMITED (HKEx), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), CSTONE PHARMACEUTICALS (HKEx), OCUMENSION THERAPEUTICS (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), ZYMEWORKS INC (NYSE), ATEA PHARMACEUTICALS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), ABBISKO CAYMAN LTD (HKEx), ICOSAVAX INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), TENAYA THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ANTENGENE CORP LTD (HKEx), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), POINT BIOPHARMA GLOBAL INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), BEYONDSPRING INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), HUA MEDICINE (HKEx), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), PHARVARIS NV (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), IGBB (Bursa), EVELO BIOSCIENCES INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), RACE ONCOLOGY LTD (ASX), EYEPOINT PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), CLEARSIDE BIOMEDICAL INC (NASDAQ), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), THERATECHNOLOGIES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), TOT BIOPHARM INTL CO LTD (HKEx), CODIAK BIOSCIENCES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NEXIMMUNE INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ATHENEX INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), DURECT CORP (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), PHARMA (Bursa), TCR2 THERAPEUTICS INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), OVID THERAPEUTICS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ANNOVIS BIO INC (NYSE American), GAMIDA CELL LTD (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), OBSEVA SA (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), TRICIDA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), MUSTANG BIO INC (NASDAQ), IP (SET), PHASEBIO PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), IX Biopharma (SGX), AYALA PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), LOGICBIO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), ODONATE THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), LANTERN PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), LANNETT CO INC (NYSE), KOTRA (Bursa), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), CRESO PHARMA LTD (ASX), YUMANITY THERAPEUTICS INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), IMARA INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), NOVA (Bursa), PAK FAH YEOW INTERNATIONAL (HKEx), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), Hyphens Pharma (SGX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EXOPHARM LTD (ASX), ABVC BIOPHARMA INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), BIOHLDG (Bursa), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), INVION LTD (ASX), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), BAUDAX BIO INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), MEDLAB CLINICAL LIMITED (ASX), SEQLL INC (NASDAQ), PALLA PHARMA LTD (ASX), ARIDIS PHARMACEUTICAL INC (NASDAQ), PHARMAXIS (ASX), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), ACER THERAPEUTICS INC (NASDAQ), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), SUNZEN (Bursa), ONCOSIL MEDICAL LIMITED (ASX), NLS PHARMACEUTICS LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), ACRUX (ASX), PAINREFORM LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), PETROS PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days -+10.000
+0.29 %
20 Days -+180.000
+5.42 %
Medium Term Return 3 Months -+110.000
+3.24 %
6 Months 122.000+200.000
+9.76 %
1 Year 122.000+420.000
+17.60 %
Long Term Return 2 Years 20532.000+720.000
+764.46 %
3 Years 23097.000-1925.000
+390.27 %
5 Years 23632.000-5750.000
+193.32 %
Annualised Return Annualised --
+24.01 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2,820.000 - 4,080.000 Change From 1 Year Low +680.000 % Change From 1 Year Low (%) +24.11
Change From 1 Year High -580.000 % Change From 1 Year High (%) -14.22
2 Years Range 1,170.000 - 4,450.000 Change From 2 Years Low +2330.000 % Change From 2 Years Low (%) +199.15
Change From 2 Years High -950.000 % Change From 2 Years High (%) -21.35
5 Years Range 1,170.000 - 9,600.000 Change From 5 Years Low +2330.000 % Change From 5 Years Low (%) +199.15
Change From 5 Years High -6100.000 % Change From 5 Years High (%) -63.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT Merck Tbk engages in the pharmaceutical and chemical businesses. It operates through the following segments: Biopharma, Consumer Health, and Others. The Biopharma segment offers ethical products. The Consumer Health segment focuses on over-the-counter products. The company was founded on October 14, 1970 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Oct 2021 3500.000 3500.000 3490.000 3500.000 240,800 3498.1146
22 Oct 2021 3490.000 3500.000 3470.000 3490.000 46,100 3490.3471
21 Oct 2021 3470.000 3540.000 3470.000 3490.000 126,900 3487.1789
19 Oct 2021 3500.000 3510.000 3440.000 3470.000 174,100 3469.9253
18 Oct 2021 3510.000 3510.000 3480.000 3500.000 180,400 3498.5643
15 Oct 2021 3500.000 3510.000 3480.000 3500.000 70,900 3503.8787
14 Oct 2021 3500.000 3520.000 3490.000 3500.000 73,900 3501.2991
13 Oct 2021 3490.000 3500.000 3490.000 3500.000 70,600 3493.0170
12 Oct 2021 3500.000 3550.000 3490.000 3490.000 123,000 3508.1626
11 Oct 2021 3510.000 3520.000 3490.000 3490.000 167,700 3504.1145
08 Oct 2021 3500.000 3540.000 3480.000 3500.000 175,600 3499.1913
07 Oct 2021 3490.000 3540.000 3480.000 3480.000 175,700 3494.8890
06 Oct 2021 3450.000 3540.000 3450.000 3490.000 591,600 3486.4351
05 Oct 2021 3580.000 3610.000 3450.000 3450.000 669,200 3551.8276
04 Oct 2021 3380.000 4080.000 3330.000 3550.000 2,428,400 3700.6457
01 Oct 2021 3290.000 3310.000 3260.000 3290.000 224,800 3287.2909
30 Sep 2021 3290.000 3290.000 3250.000 3290.000 75,100 3278.7350
29 Sep 2021 3290.000 3290.000 3280.000 3290.000 213,300 3287.7543
28 Sep 2021 3330.000 3330.000 3290.000 3290.000 18,400 3302.0652
27 Sep 2021 3330.000 3340.000 3300.000 3320.000 62,100 3315.7166
24 Sep 2021 3340.000 3340.000 3300.000 3330.000 37,300 3315.8445
23 Sep 2021 3320.000 3340.000 3320.000 3340.000 21,300 3336.9484
Summary
Current 2 Weeks
(11 Oct 2021 to 25 Oct 2021)
3510.000 3550.000 3440.000 3500.000 1,274,400 -
Previous 2 Weeks
(27 Sep 2021 to 08 Oct 2021)
3330.000 3550.000 3300.000 3500.000 4,634,200 -
4 Weeks from
(30 Aug 2021 to 24 Sep 2021)
3400.000 3550.000 3340.000 3330.000 811,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.